trial · primary record
Ramosetron
Fecal Incontinence
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 147 |
| Primary completion | 2026-12-30 |
| Primary endpoint | Change in total Fecal Incontinence Severity Index (FISI) from baseline to 1 month |
| Registry ID | NCT06166615 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:10.324Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06166615
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.